Pancreatic Ductal Adenocarcinoma — Trials

Pancreatic Ductal Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

414 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 208
Recruiting: 129
Ph III recruiting: 13
Growth YoY: +56.5%
Industry share: 50%
Top sponsor: Revolution Medicines, Inc.
Termination share: 46.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (56)

clinicaltrialsPublishedShowing 101–108 of 108 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07106827	A Study of GV20-0251 in Advanced or Refractory Solid Tumors	recruiting	Phase 1	10	West China HospitalOTHER	1	Nov 24, 2025	clinicaltrials
NCT04821284	Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer	active not recruiting	Phase 1 / Phase 2	120	Flemming ForsbergOTHER	2	Nov 4, 2025	clinicaltrials
NCT04888312